Livzon Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 5/6
Livzon Pharmaceutical Group has a total shareholder equity of CN¥15.4B and total debt of CN¥3.6B, which brings its debt-to-equity ratio to 23%. Its total assets and total liabilities are CN¥25.2B and CN¥9.8B respectively. Livzon Pharmaceutical Group's EBIT is CN¥2.0B making its interest coverage ratio -5.7. It has cash and short-term investments of CN¥11.2B.
Key information
23.0%
Debt to equity ratio
CN¥3.56b
Debt
| Interest coverage ratio | -5.7x |
| Cash | CN¥11.23b |
| Equity | CN¥15.44b |
| Total liabilities | CN¥9.75b |
| Total assets | CN¥25.19b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 000513's short term assets (CN¥17.2B) exceed its short term liabilities (CN¥8.3B).
Long Term Liabilities: 000513's short term assets (CN¥17.2B) exceed its long term liabilities (CN¥1.4B).
Debt to Equity History and Analysis
Debt Level: 000513 has more cash than its total debt.
Reducing Debt: 000513's debt to equity ratio has increased from 0.01% to 23% over the past 5 years.
Debt Coverage: 000513's debt is well covered by operating cash flow (108.9%).
Interest Coverage: 000513 earns more interest than it pays, so coverage of interest payments is not a concern.